Year-Long test for new ADHD pill in kids
NCT ID NCT07087327
Summary
This study aims to check the long-term safety of a daily medication called EB-1020 for children and teenagers with ADHD. It will follow about 180 participants for 52 weeks to see how they tolerate the treatment. The main goal is to monitor for any side effects that may occur during this extended period of use.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
Locations
-
Hokkaido University Hospital
RECRUITINGSapporo, Japan
Conditions
Explore the condition pages connected to this study.